Neurology Clinical Trials: FOMAT Partners With Link Neuroscience Institute
Neurology clinical trials focused on Parkinson’s, Alzheimer’s, and movement disorders are advancing through a powerful new partnership between FOMAT and Link Neuroscience Institute, led by Dr. Bradley Hiner, a renowned expert in neurology. This collaboration brings together the resources and expertise of both organizations to accelerate breakthroughs in some of the most challenging and underserved areas of modern medicine.
Expanding Neurology Clinical Trials Capabilities
The partnership is designed to enhance FOMAT’s neurology clinical trials program by leveraging Dr. Hiner’s standing as a Key Opinion Leader in Parkinson’s disease, Alzheimer’s disease, and movement disorders. Together, the two organizations are positioned to offer a premier platform for developing and testing new therapies in these critical therapeutic areas.
Simon Corman, Chief Growth Officer at FOMAT, emphasized the significance of the collaboration: “By joining forces with Link Neuroscience Institute, we are opening new pathways to discover effective treatments for neurological disorders. This partnership brings us closer to improving the lives of patients worldwide.”
This alliance underscores FOMAT’s commitment to addressing critical unmet medical needs through innovative research and through partnerships with leading clinical experts who bring both scientific depth and patient centered experience to every study.
A Stanford Trained Neurologist Leading the Way
Dr. Hiner is a Stanford trained neurologist with extensive experience in both research and patient care. His leadership of Link Neuroscience Institute reflects a mission to advance science and improve outcomes for patients living with complex neurological conditions. The partnership with FOMAT enables access to a broader range of neurology clinical trials, offering new hope to patients and families affected by Parkinson’s, Alzheimer’s, and related disorders.
Link Neuroscience Institute, based in Oxnard and Santa Barbara, combines specialized diagnostics and advanced treatments for neurological conditions. The institute’s integration into FOMAT’s research network creates a seamless environment where clinical expertise and research infrastructure work together to generate high quality data and deliver meaningful patient access.
Benefits for Sponsors, CROs, and Patients
For sponsors and CROs evaluating neurology clinical trials sites in Southern California, this partnership provides a robust and experienced platform for trial execution and data collection. The combined capabilities of FOMAT and Link Neuroscience Institute accelerate the development of innovative therapies while ensuring consistent quality, compliance, and diverse patient enrollment.
For patients with neurological conditions, the partnership opens direct access to the latest advancements in research and treatment. Participating in neurology clinical trials at a site led by a KOL of Dr. Hiner’s caliber means access to cutting edge therapies that may not otherwise be available locally — alongside a care team deeply committed to improving quality of life for every participant.
The inclusion of neurology clinical trials within FOMAT’s network also addresses a growing demand from the pharmaceutical industry for sites that can enroll diverse patient populations in complex neurological studies. Conditions like Parkinson’s and Alzheimer’s disproportionately affect older adults and certain ethnic communities, making diverse and community connected sites like Link Neuroscience Institute essential for generating data that reflects real world patient populations.
Beyond enrollment, the partnership strengthens the overall quality of neurology clinical trials by pairing FOMAT’s centralized operational support — including regulatory guidance, data management, and quality assurance — with Dr. Hiner’s frontline clinical expertise. This integrated approach reduces operational burden on sponsors and CROs while maintaining the scientific rigor and patient safety standards that define successful early and late phase neurological research.
A Growing Network Built for Neurological Research
FOMAT’s partnership with Link Neuroscience Institute is part of a broader strategy to expand its capabilities across specialized therapeutic areas nationally. By integrating expert led sites like Link Neuroscience Institute into its network, FOMAT continues to offer sponsors and CROs access to diverse, experienced, and operationally strong research sites across the United States.
Read the full press release: FOMAT Partners With Link Neuroscience Institute to Drive Neurology Research Advancements.
To learn more about FOMAT’s neurology research capabilities and other therapeutic areas, visit our Physician Investigator Network page or explore our Active Studies to find current opportunities near you.
Read the full press release: FOMAT Partners With Link Neuroscience Institute to Drive Neurology Research Advancements.